• Methotrexate sodium salt packaged and labeled.

click on thumbnail to zoom
SKU: M031

Size  
Quantity:
  Click 'Bulk Order' for 10 or more
Price: make selection(s)
Description

Methotrexate sodium salt is a selective agent for dihydrofolate reductase (DHFR)- transfected cells, and a nucleic acid synthesis inhibitor in protein expression systems, thus can be used as an ancillary material in upstream biomanufacturing applications.     It also has immunosuppressive effects for rheumatoid arthritis research and has anti-cancer properties. Methotrexate sodium salt is freely soluble in aqueous solution.

We also offer:

  • Methotraxate (M027)
  • Methotrexate, EvoPure® (M091)

This product is considered a dangerous good. Quantities above 1 g may be subject to additional shipping fees. Please contact us for questions.

    CAS Number

    7413-34-5

    Molecular Formula

    C20H20N8Na2O5

    Molecular Weight

    498.40

    Mechanism of Action

    In cancerous cells, Methotrexate acts as an allosteric inhibitor of dihydrofolate reductase (DHFR), an enzyme involved in the folic acid metabolic pathway. Folic acid is essential in cells because it is required for thymidine and purine synthesis. Methotrexate therefore acts as a nucleic acid synthesis inhibitor.

    Storage Conditions

    -20 °C

    Tariff Code

    2933.59.2600

Applications

    Application

    Methotrexate can be used for antitumor studies.

    Cancer Applications

    Methotrexate sodium salt acts as a chemotherapeutic agent by inhibiting nucleic acid synthesis in cancer cells.

    Eukaryotic Cell Culture Applications

    Methotrexate is commonly used in the dihydrofolate reductase (DHFR) selection system as a selection antibiotic to select for DHFR- deficient CHO cells that have been transfected with DHFR genes. Methotrexate inhibits the activity of DHFR; however, cells that overproduce DHFR can tolerate higher concentrations of methotrexate. In most cases, overproducing DHFR cells produce more recombinant protein than lower DHFR producing cells.

    CHO cells and other mammalian cells used in biopharma manufacturing may exhibit toxicity to USP-grade products.  Our Methotrexate, EvoPure® has been purified to remove toxic impurities.  If you have unique specifications for your system, please contact us.

    Insect Biology Applications

    Methotrexate is effective for pyrimethamine-resistant Plasmodium vivax malaria parasites.

Specifications

    Form

    Powder

    Appearance

    Yellow Powder

    Source

    Synthetic

    Impurity Profile

    Impurity A| (2,4-Diaminopteridin-6-yl)methanol Hydrochloride|945-24-4|C7H8N6O|192.18| Impurity B| (2S)-2-[[4-[[(2,4-diaminopteridin-6-yl)methyl]amino]benzoyl]amino]pentanedioic acid; N-Desmethyl Methotrexate|54-62-6|C19H20N8O5|440.41| Impurity C| (2S)-2-[[4-[[(2-amino-4-hydroxy pteridin-6-yl) methyl] methyl amino] benzoyl] amino] pentanedioic acid ; Methotrextae 4-Oxo Analog |2410-93-7|C20H21N7O6|455.42| Impurity D| 4-[[(2-amino-4-hydroxypteridin-6-yl)methyl] methylamino]benzoic acid; N10-Methylpteroic acid|5623-18-7|C15H14N6O3|326.31| Impurity E| 4-[[(2,4-Diaminopteridin-6-yl) methyl] methyl amino]benzoic acid; 2,4-Diamino-N10-methylpterioc acid|70844-48-3|C15H15N7O2|325.33| Impurity F| (2R)-2-[[4-[[(2,4-Diaminopteridin-6-yl)methyl]methylamino]benzoyl] amino] pentanedioic acid ; (R)-Methotrexate||C20H22N8O5|454.44| Methotrexate Dimethyl Ester| N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid dimethyl ester; Dimethyl Methotrexate|34378-65-9|||7-Hydroxy Methotrexate|4-Amino-7-hydroxy-10-methylpteroylglutamic acid|5939-37-7|C20H22N8O6|470.44|

References

    References

    Fairbanks, LD et al (1999)  Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: A metabolic basis for efficacy in rheumatoid arthritis? Biochem. J 342 (1):143-52

    Kingston RE, Kaufman RJ, Bebbington CR and Rolfe MR (2002)  Amplification using CHO cell expression vectors. Curr. Protoc. Mol. Biol. Chapter 16:Unit 16.23  PMID 18265304

    Maleki H et al (2017)  Methotrexate-loaded PLGA nanoparticles: Preparation, characterization and their cytotoxicity effect on human glioblastoma U87MG cells. Med. Nano. Res. 4(1):020

Other Items In This Category